165 related articles for article (PubMed ID: 23745147)
1. CHOP THERAPY INDUCED MITOCHONDRIAL REDOX STATE ALTERATION IN NON-HODGKIN'S LYMPHOMA XENOGRAFTS.
Xu HN; Zhao H; Mir TA; Lee SC; Feng M; Choe R; Glickson JD; Li LZ
J Innov Opt Health Sci; 2013 Apr; 6(2):1350011. PubMed ID: 23745147
[TBL] [Abstract][Full Text] [Related]
2. Mapping the redox state of CHOP-treated non-Hodgkin's lymphoma xenografts in mice.
Xu HN; Mir TA; Lee SC; Feng M; Farhad N; Choe R; Glickson JD; Li LZ
Adv Exp Med Biol; 2013; 789():243-249. PubMed ID: 23852501
[TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
4. REDOX IMAGING OF THE p53-DEPENDENT MITOCHONDRIAL REDOX STATE IN COLON CANCER
Xu HN; Feng M; Moon L; Dolloff N; El-Deiry W; Li LZ
J Innov Opt Health Sci; 2013 Jul; 6(3):. PubMed ID: 26207147
[TBL] [Abstract][Full Text] [Related]
5. QUANTITATIVE REDOX SCANNING OF TISSUE SAMPLES USING A CALIBRATION PROCEDURE.
Xu HN; Wu B; Nioka S; Chance B; Li LZ
J Innov Opt Health Sci; 2009 Oct; 2(4):375-385. PubMed ID: 31827629
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the metabolic heterogeneity in human breast cancer xenografts by 3D high resolution fluorescence imaging.
Xu HN; Zheng G; Tchou J; Nioka S; Li LZ
Springerplus; 2013 Dec; 2(1):73. PubMed ID: 23543813
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Optical Redox Imaging of Melanoma Xenografts with Different Metastatic Potentials.
Peng A; Xu HN; Moon L; Zhang P; Li LZ
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730620
[TBL] [Abstract][Full Text] [Related]
8. Optical Redox Imaging of Lonidamine Treatment Response of Melanoma Cells and Xenografts.
Xu HN; Feng M; Nath K; Nelson D; Roman J; Zhao H; Lin Z; Glickson J; Li LZ
Mol Imaging Biol; 2019 Jun; 21(3):426-435. PubMed ID: 30151646
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of mitochondrial redox state in premalignant pancreas in a PTEN null transgenic mouse model.
Xu HN; Nioka S; Chance B; Li LZ
Adv Exp Med Biol; 2011; 701():207-13. PubMed ID: 21445789
[TBL] [Abstract][Full Text] [Related]
10. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
11. In vivo MRS markers of response to CHOP chemotherapy in the WSU-DLCL2 human diffuse large B-cell lymphoma xenograft.
Lee SC; Huang MQ; Nelson DS; Pickup S; Wehrli S; Adegbola O; Poptani H; Delikatny EJ; Glickson JD
NMR Biomed; 2008 Aug; 21(7):723-33. PubMed ID: 18384181
[TBL] [Abstract][Full Text] [Related]
12. 3D IMAGING OF THE MITOCHONDRIAL REDOX STATE OF RAT HEARTS UNDER NORMAL AND FASTING CONDITIONS.
Xu HN; Zhou R; Moon L; Feng M; Li LZ
J Innov Opt Health Sci; 2014 Mar; 7(2):1350045. PubMed ID: 24917891
[TBL] [Abstract][Full Text] [Related]
13. In vivo (1)H MRS of WSU-DLCL2 human non-Hodgkin's lymphoma xenografts: response to rituximab and rituximab plus CHOP.
Lee SC; Delikatny EJ; Poptani H; Pickup S; Glickson JD
NMR Biomed; 2009 Apr; 22(3):259-65. PubMed ID: 19040203
[TBL] [Abstract][Full Text] [Related]
14. MITOCHONDRIAL REDOX IMAGING FOR CANCER DIAGNOSTIC AND THERAPEUTIC STUDIES.
Li LZ; Xu HN; Ranji M; Nioka S; Chance B
J Innov Opt Health Sci; 2009 Oct; 2(4):325-341. PubMed ID: 26015810
[TBL] [Abstract][Full Text] [Related]
15. Quantitative mitochondrial redox imaging of breast cancer metastatic potential.
Xu HN; Nioka S; Glickson JD; Chance B; Li LZ
J Biomed Opt; 2010; 15(3):036010. PubMed ID: 20615012
[TBL] [Abstract][Full Text] [Related]
16. IMAGING REDOX STATE HETEROGENEITY WITHIN INDIVIDUAL EMBRYONIC STEM CELL COLONIES.
Xu HN; Addis RC; Goings DF; Nioka S; Chance B; Gearhart JD; Li LZ
J Innov Opt Health Sci; 2011 Jul; 4(3):279-288. PubMed ID: 34046096
[TBL] [Abstract][Full Text] [Related]
17. Quantitative redox imaging biomarkers for studying tissue metabolic state and its heterogeneity.
Xu HN; Li LZ
J Innov Opt Health Sci; 2014 Mar; 7(2):. PubMed ID: 31827630
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
19. Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).
Wunderlich A; Kloess M; Reiser M; Rudolph C; Truemper L; Bittner S; Schmalenberg H; Schmits R; Pfreundschuh M; Loeffler M;
Ann Oncol; 2003 Jun; 14(6):881-93. PubMed ID: 12796026
[TBL] [Abstract][Full Text] [Related]
20. Optical Redox Imaging of Fixed Unstained Muscle Slides Reveals Useful Biological Information.
Xu HN; Zhao H; Chellappa K; Davis JG; Nioka S; Baur JA; Li LZ
Mol Imaging Biol; 2019 Jun; 21(3):417-425. PubMed ID: 30977079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
